Inventor

OHTANI MITSUAKI

JP50 patents

⚠️ This page may combine multiple inventors who share the name “OHTANI MITSUAKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OHTANI MITSUAKI

SHIONOGI & CO

Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same

Epimerization of malonic acid esters

Aromatic-sulfonamide-type hydroxamic acid derivative

Para-terphenyl compounds

P-terphenyl compounds

Para-terphenyl compounds

Pyrrolotriazine derivatives having spla2-inhibitory activities

Pyrrolidine derivatives having phospholipase A2 inhibitory activity

Pyrrolidine derivatives having phospholipase A2 inhibitory activity

Preparation of optically active 1,4-bridged-cyclohexane carboxylic acid derivatives

Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect

Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same

Bicyclic amino derivatives and PGD2 antagonist containing the same

Bicyclic sulfonamide derivatives

Oxazolinone derivatives having cytosolic phospholipase A2 inhibitory activity

Pyrrolo[1,2-a]pyrazine spla2 inhibitor

Process of producing ether-type thio-phospholipids

Certain optically active mono esters of dicarboxylic acids

6-oxa and thiabicyclo [3.1.0.] compounds

Bicyclic sulfonamide derivatives

Bicyclic amino derivatives and PGD2 antagonist containing the same

Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same

Bicyclic amino derivatives and PGD2, antagonist containing them

Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same

Sulfonylamino substituted bicyclo [2.2.1]heptane hydroxamic acid derivatives useful as pharmaceuticals

5(Z)-7-(endo-3-benzenesulfonamidobicyclo[2.2.1]hept-exo-2-yl)-5-heptenoic acid, sodium salt

Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same

Tricyclic compounds having sPLA2-inhibitory activities

Tricyclic compounds having sPLA2-inhibitory activities

Process of producing ether-type thio-phospholipids

Mono ester of dicarboxylic acid

Monoesters of arylacetic acid and the process thereof

Process for preparing 1,4-bridged cyclohexane carboxylic acid derivatives

Compound and composition of substituted hexenoic acid derivatives useful for treating thromboxane A2 mediated diseases

7-oxabicyclo[2.2.1] heptane sulfonamide derivatives

Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same

Phospholipase A2 inhibitor

Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity

Preparation of norbornyl sulfonamide derivatives

Bicyclo (2.2.1.) hept-exo-2-yl and bicyclo (2.2.2.) oct-endo-2-yl compounds

Intermediates for preparation of 2,3-trans-1,4-bridged cyclohexane sulfonamide derivatives

Preparation of 2,3-trans-1,4-bridged cyclohexane sulfonamide derivatives

Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same

Process of producing ether-type thio-phospholipids

Mono ester of dicarboxylic acid and process thereof

Mono ester of dicarboxylic acid and process thereof

Alkenyltetrazole derivatives

Method for the reduction of allyl alcohols

LILLY CO ELI

Indolizine SPLA2inhibitors

Indene-1-acetamide sPLA2 inhibitors